Analytical Data
-
基因名
PQLC2
- Application
-
别名
SLC66A1; PQLC2; Lysosomal amino acid transporter 1 homolog; PQ-loop repeat-containing protein 2; Solute carrier family 66 member 1
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6ZP29
-
表达区间
1-226 aa
-
氨基酸序列
MDQALSLWFLLGWIGGDSCNLIGSFLADQLPLQTYTAVYYVLADLVMLTLYFYYKFRTRPSLLSAPINSVLLFLMGMACATPLLSAAGPVAAPREAFRGRALLSVESGSKPFTRQEVIGFVIGSISSVLYLLSRLPQIRTNFLRKSTQGISYSLFALVMLGNTLYGLSVLLKNPEEGQSEGSYLLHHLPWLVGSLGVLLLDTIISIQFLVYRRSTAASELEPLLPS
-
分子量
51.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PQLC2 (Pseudomonas putida quinone permease-like 2) is a member of the solute carrier family and has garnered significant attention due to its potential roles in various physiological and pathological processes. It is primarily identified as a membrane protein with a unique function in transporting specific metabolites across cellular membranes. Recent studies suggest that PQLC2 is involved in the response to cellular stress and plays a role in maintaining cellular homeostasis. Given the increasing incidence of metabolic disorders and the need for novel therapeutic strategies, understanding the functional mechanisms of PQLC2 and its interactions with other molecular targets is essential. Research has also highlighted its potential implications in cancer biology, as altered expression of PQLC2 may influence tumor progression and drug resistance. Therefore, the recombinant expression of PQLC2 in various model systems is critical for elucidating its structure-function relationships and for developing targeted interventions. By producing and characterizing recombinant PQLC2, researchers aim to shed light on its transport mechanisms and to explore its potential as a biomarker or therapeutic target in metabolic and oncological diseases. This research underlines the importance of PQLC2 in both basic and translational science, paving the way for future investigations into its pharmacological significance and therapeutic applications.
